CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling

Chemoresistance remains an obstacle to the successful treatment of ovarian carcinoma. CUE domain-containing 2 (CUEDC2) plays critical roles in tumor genesis and overexpresses in many solid cancers, including ovarian serous carcinoma. In previous study, we found that overexpression of CUEDC2 might be...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Wang, Aichun, Li, Jinhang, Zhou, Tao, Li, Tao, Cai, Hong, Shi, Huaiyin, Liu, Aijun
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2019
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547988/
https://ncbi.nlm.nih.gov/pubmed/31205536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.29889
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki